Search

Search Constraints

You searched for: Author/Creator Popp, Julius

Search Results

31. Inflammatory biomarkers in Alzheimer's disease plasma. Issue 6 (29th April 2019)

33. Neurofilament light and cognitive performance: Associations with amyloid and vascular pathologies in individuals with mild cognitive impairment: Biomarkers (non‐neuroimaging): EEG and other biomarkers. (7th December 2020)

34. Neuropsychiatric symptoms, Alzheimer's Disease and Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate: a Prospective Study. (20th December 2022)

35. Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease. Issue 1 (31st May 2017)

36. O5‐05‐03: ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT‐LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS. (1st July 2019)

37. Obstructive sleep apnoea and 5-year cognitive decline in the elderly. Issue 4 (27th April 2023)

38. P2‐147: A Neuroinflammatory Biomarker Signature of Blood‐Brain Barrier Impairment in Older Adults. (1st July 2016)

39. P2‐159: Markers of Neuroinflammation Associated with Alzheimer's Disease Pathology in Older Adults. (1st July 2016)

40. P2‐242: PATHOPHYSIOLOGICAL SUBTYPES OF ALZHEIMER'S DISEASE BASED ON CEREBROSPINAL FLUID PROTEOMICS. (1st July 2019)